Jänne, P. A., Planchard, D., Kobayashi, K., Yang, J. C., Liu, Y., Valdiviezo, N., Kim, T. M., Jiang, L., Kagamu, H., Yanagitani, N., Wang, J., Biswas, B., Poltoratskiy, A., Neron, Y., Rojas, C., Koubkova, L., Escriu, C., Ezeife, D. A., Mann, H., Armenteros-Monterroso, E., Rukazenkov, Y., Lee, C. K. (2026). Survival with Osimertinib plus Chemotherapy in
                    <i>EGFR</i>
                    -Mutated Advanced NSCLC. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2510308